Sarepta???s Exondys 51 Saga Continues as More Details About FDA???s Criticism Uncovered Post author:Sam Post published:August 21, 2017 Post category:BioPharma August 22, 2017By Mark Terry… Source: BioSpace You Might Also Like Vapourtec Expands With New Headquarters And Plans For Job Creation April 13, 2017 Ipsen Announces Oral And Poster Presentations Of Abobotulinumtoxina Data At The 2017 Annual Meeting Of September 14, 2017 Phase I Clinical Data Of ABX464, ABIVAX's First-In-Class Anti-HIV Drug, Published In Two Articles In Peer-Reviewed Journals February 2, 2017
Ipsen Announces Oral And Poster Presentations Of Abobotulinumtoxina Data At The 2017 Annual Meeting Of September 14, 2017
Phase I Clinical Data Of ABX464, ABIVAX's First-In-Class Anti-HIV Drug, Published In Two Articles In Peer-Reviewed Journals February 2, 2017
